Cannabidiol for Reduction of Brain Neuroinflammation
Phase 2
80
about 4.9 years
18–75
1 site in MA
About this study
Researchers are testing whether cannabidiol (CBD), a treatment, can reduce brain inflammation in adults with chronic pain and/or depression. The trial will last 1806 days.
Based on ClinicalTrials.gov records.
What participants do
- 1.Placebo
- 2.Take CBD
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
cannabinoid
Secondary: Change in Clinical Pain Ratings, Change in Depressive Symptoms, Change in Pain Bothersomeness, Correlation Between Reductions in Limbic [11C]PBR28 PET Signal and Reductions in Depressive Symptoms, Correlation Between Reductions in Thalamic [11C]PBR28 PET Signal and Reductions in Clinical Pain Ratings, Patient Global Impression of Change
Psychiatry / Mental Health